LC
RXST icon

Lindbrook Capital’s RxSight RXST Stock Holding History

Lindbrook Capital’s Portfolio RXST Stock Details RXST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.26K Buy
+50
New +$1.49K ﹤0.01% 2402

Other funds holding RXST

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $2.39B AUM 134.55% 1-Year Est. Return

Lindbrook Capital's RXST Position: Q1 2025 in Review

Lindbrook Capital opened a new position in RxSight (RXST) in Q1 2025: 50 shares worth $1.26K. The stake represents ﹤0.01% of the portfolio and ranks #2402 among its holdings.

192 funds tracked by Wall St. Rank hold RXST as of Q1 2025.

  • Lindbrook Capital held 50 shares of RxSight worth $1.26K as of Q1 2025.
  • RxSight was a new Lindbrook Capital position in Q1 2025.
  • RxSight made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2402 holding.
  • 192 funds tracked by Wall St. Rank held RxSight as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.